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Abstract Fruits, nuts, legumes, and vegetables are rich
sources of boron (B), an essential plant nutrient with chemo-
preventive properties. Blood boric acid (BA) levels reflect
recent B intake, and men at the US mean intake have a report-
ed non-fasting level of 10 μM. Treatment of DU-145 prostate
cancer cells with physiological concentrations of BA inhibits
cell proliferation without causing apoptosis and activates eu-
karyotic initiation factor 2 (eIF2α). EIF2α induces cell differ-
entiation and protects cells by redirecting gene expression to
manage endoplasmic reticulum stress. Our objective was to
determine the temporal expression of endoplasmic reticulum
(ER) stress-activated genes in DU-145 prostate cells treated
with 10 μM BA. Immunoblots showed post-treatment in-
creases in eIF2α protein at 30 min and ATF4 and ATF6 pro-
teins at 1 h and 30 min, respectively. The increase in ATF4
was accompanied by an increase in the expression of its down-
stream genes growth arrest and DNA damage-induced protein
34 (GADD34) and homocysteine-induced ER protein (Herp),
but a decrease in GADD153/CCAAT/enhancer-binding pro-
tein homologous protein (CHOP), a pro-apoptotic gene. The
increase in ATF6 was accompanied by an increase in
expression of its downstream genes GRP78/BiP, calreticulin,
Grp94, and EDEM. BA did not activate IRE1 or induce cleav-
age of XBP1 mRNA, a target of IRE1. Low boron status has
been associated with increased cancer risk, low bone mineral-
ization, and retinal degeneration. ATF4 and BiP/GRP78
function in osteogenesis and bone remodeling, calreticulin is
required for tumor suppressor p53 function and mineralization
of teeth, and BiP/GRP78 and EDEM prevent the aggregation
of misfolded opsins which leads to retinal degeneration. The
identification of BA-activated genes that regulate its pheno-
typic effects provides a molecular underpinning for boron
nutrition and biology.
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Background
Boron (B) intake is associated with reduced risk of prostate
cancer in men [1–5], lung cancer in women [6], improvement
in executive brain function [7], bone mineralization and
strength [8–10], and a decrease in inflammation in animals
[11]. Plants require boron as an essential nutrient and are the
major source of boron in the human diet [12]. Greater than
90 % of dietary boron is absorbed and distributed to tissues as
boric acid (BA) (WHO 1998) with 98 % eliminated in the
urine after 120 h (Jansen et al. 1984). A study of men working
in a large boric acid borax production plant found no differ-
ences in boron blood levels between workers with high and
low occupational [13] exposure at the beginning of their 5-day
work week [13]. Monday pre-shift non-fasting blood BA
levels averaged 9.7 μM in these workers whose average die-
tary intake of 1.35 mg B/day was near the mean US intake of
1.42 mg/day for men over 30 years of age [12].
Human prostate cells were developed as a model for inves-
tigating the molecular cell biology of BA after epidemiologi-
cal evidence showed that boron was associated with reduced
risk of prostate cancer [3, 5]. Treatment of LNCaP and DU-
145 prostate cancer cells with physiological concentrations or
BA inhibits cell proliferation in a dose-dependent manner [5]
without causing apoptosis but shifts them into a senescent-like
phenotype [5, 14]. BA binds to cADPR and inhibits cADPR-
activated Ca2+ release from the endoplasmic reticulum (ER) in
a dose-dependent manner [15, 16] and lowers ER luminal
Ca2+ concentrations. Low ER luminal Ca2+ induces phosphor-
ylation of eIF2α, a major regulator of cellular responses to
environmental stress [17]. In MEF cells, low activation of
eIF2α activates the transcription factor ATF4 which induces
genes in the integrated stress response, but not the CCAAT/
enhancer-binding protein homologous protein (CHOP), an
apoptotic gene, whereas high activation induces CHOP.
Phosphorylation of eIF2α occurs following BA treatment of
DU-145 and LNCaP prostate cells [18–20] and yeast [21]. In
humans, blood levels of BA are dynamic, rising rapidly after a
meal with an elimination half-life from 4 to 27.8 h depending
on dose [22, 23]. Here, we treated DU-145 cells with a con-
stant BA concentration of 10 μM, the level reported in men at
the mean US boron dietary intake, and measured the temporal
response of genes in the ER stress pathways.
Methods
Chemical
DMSO, DTT, boric acid, NaCl, Tris, methanol, MgCl2, su-
crose, and methanol were purchased from Sigma-Aldrich (St.
Louis, MO). Triton X-100, Tween-20, NP40, and cyclohexi-
mide were purchased from Fisher Scientific (Pittsburg, PA).
Paraformaldehyde was purchased from Affymetrix/USB
Corporation (Cleveland, OH). Thapsigargin and BSA were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Phosphatase inhibitors and protease were purchased
from Calbiochem (San Diego, CA), and fetal bovine serum
(FBS) was purchased from Gibco-Life Sciences (Grand
Island, NY).
Cell Culture
DU-145 prostate cancer cells were purchased from the
American Type Culture Collection (Manassas, VA) and sub-
cultured at a ratio of 1:6 and used for seven passages. The
ATCC description of the DU-145 karyotype is given in
Supplement 2 [24]. DU-145 is included in the COSMIC
Cell Line Project, and available information for each gene
measured in this paper is given in Tables 1-6 of Supplement
2. The cell culture medium was RPMI-1640 Medium (Gibco-
Life Technologies, Grand Island, NY) supplemented with
10 % FBS, L-glutamine (200 mM), streptomycin (100 μg/
mL), and penicillin (100 U/mL) (Gemini Bio Products,
Sacramento, CA). Cells were plated on 10- or 15-cm plates
(Corning Life Sciences, Corning, NY) and incubated in a hu-
midified chamber at 37 °C and 5 % CO2 and 95 % air to 80 %
confluency. Media used for all treatment groups were first
stripped of boron by shaking with 2 g of Amberlite IRA 743
exchange resin (Sigma-Aldrich) for 12 h at 4 °C. H2O or BA
(10 mM) was added respectfully to prepare untreated and
10 μM BA cell culture media [25]. Cells were cultured in
untreated media until 80 % confluency and sub-cultured for
experiments using untreated media or media adjusted to
10 μM BA.
Polysome Profile
Polysome profiles were developed from untreated and BA-
treated cells obtained from paired culture plates and processed
in parallel. Plated cells were incubated in culture media con-
taining 50 μg/mL cycloheximide for 10 min at 37 °C. Plates
were then chilled on ice, the media removed, and cells were
rinsed two to three times with ice-cold PBS containing 50 μg/
mL cycloheximide. The cells were lysed in 500 μl lysis buffer
(20 mM Tris (pH 7.5), 100 mM NaCl, 10 mM MgCl2, 0.4 %
NP-40, 50 μg/mL cycloheximide, and protease and phospha-
tase inhibitors. The lysate was scraped with a spatula
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(Corning) and transferred to a microcentrifuge tube. The ly-
sate was passed through a sterile 23-gauge needle (BD,
Franklin Lakes, NJ) 8–10 times and incubated on ice for
10 min. The lysate was centrifuged at 8000×g for 10 min,
and the supernatant was used for the polysome profile. The
gradient was prepared by filling a SW41 centrifuge tube ap-
proximately halfway with 10 % gradient solution [20 mM
Tris–HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.5 mM
DTT, 0.1 mg/mL cycloheximide, and 10 % sucrose (w/v)].
A 23-gauge needle was used to add solution containing
20 mM Tris–HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2,
0.5 mM DTT, 0.1 mg/mL cycloheximide, and 50 % (v/w)
sucrose to the bottom of the tube to form the lower layer. A
gradient maker was used to create a 10–50 % gradient. Lysate
with OD of 10 (up to 800 μl) was gently added to the top of
the gradient. The tubes were balanced, gently placed in a pre-
cooled SW41 rotor (Beckman Coulter, Brea, CA), and centri-
fuged for 3 h at 35,000 rpm. Fifty fractions were collected
through a 23-gauge needle inserted through the bottom of
the tube and immediately placed on ice. The absorbance of
each fraction was measured at 254 nm. Monosomes and poly-
somes were quantified by measuring the area under the 80S
monosomal peak and the area under the polysomes using the
trapezoidal area under the curve method.
Immunoblot Analysis
DU-145 cells were grown to 80% confluency on 15-cm plates
(Corning) and treated with 10 μM BA, 1 μM thapsigargin, or
DMSO positive control vehicle for various times. Cells were
washed with ice-cold phosphate buffer solution (PBS) supple-
mented with 0.1 % Tween (PBST) and treated with 100 μl
radioimmunoprecipitation assay (RIPA) lysis buffer. Actin
and GAPDHwere used as loading controls and selected based
on their molecular mass band separation from the protein of
interest. Cells were scraped from plates using a spatula
(Corning) placed on ice, and the lysate was passed through a
23-gauge needle (BD) 8–10 times. The protein was quantitat-
ed using Coomassie Plus Protein Assay (Thermo-Scientific,
Waltham, MA). Aliquots containing 30–35 μg protein sample
were separated using a 4–12 % gradient TGX SDS-PAGE
(Bio-Rad, Hercules, CA) at 200 V for 30 min. Protein was
transferred to a nitrocellulose membrane using a transfer buff-
er containing 20 % methanol at 40 V for 1.5 h. Membranes
were blocked in 3 % BSAwith 37.5 mM Tris (pH 8.8), 0.1 %
Tween 20, and 125 mMNaCl for at least 4 h. Antibodies were
selected from commercial suppliers based on their specificity
for human orthologs and validated by comparison of immu-
noblot bands to standard molecular mass ladders (Bio-Rad).
Antibody dilutions were selected based on testing of lots prior
to use in experiments and ranged from 1:200 to 1:1000.
Blocked membranes were incubated with the primary anti-
body for 1 h in PBST or 3 % BSA blocking solution and
washed in PBST. They were then incubated with a secondary
antibody with an HRP tag, followed by washing three times
with PBST. The membranes were exposed to ECL Plus
(Amersham/GE Healthcare, Pittsburg, PA) for 2–5 min and
imaged using a Typhoon 9410 Variable Mode Imager
(Amersham). Densitometry was performed using
ImageQuant 5.2 software (Molecular Dynamics, Pittsburg,
PA). All secondary antibodies were purchased from Santa
Cruz Biotechnologies (Santa Cruz, CA). The following pri-
mary antibodies from Santa Cruz Biotechnology were used:
GRP78/BiP (mouse monoclonal), Actin (goat polyclonal),
GAPDH (mouse monoclonal), ATF4 (rabbit polyclonal),
GADD34 (rabbit polyclonal), CHOP/Gadd153 (rabbit poly-
clonal), XBP-1 (rabbit polyclonal), and ATF6α (rabbit poly-
clonal). The eIF2α (rabbit polyclonal) and ph-eIF2α (rabbit
polyclonal) antibodies were purchased from Cell Signaling
(Danvers, MA), and ATF6 (mouse monoclonal) was pur-
chased from Imgenex (San Diego, CA).
TaqMan Real-Time PCR
DU-145 cells were grown on 10-cm plates (Corning) to 80 %
confluency at least 24 h prior to treatment. Cells were treated
with 10 μM BA, 1 μM thapsigargin, or DMSO vehicle for
varying time points. RNAwas isolated from cells at indicated
time points (0, 0.25, 0.5, 1, 2, 3, 4, 5, 6, 12, or 24 h) using an
RNeasy Mini Kit (Qiagen, Valencia, CA). Total RNA (2 μg)
was reverse transcribed using Superscript III Reverse
Transcriptase (Invitrogen) with random hexamer primers
(Invitrogen) at a final volume of 20 μl at 25 °C, 10 min
(10:00); 50 °C, 45:00; and 70 °C, 15:00. Applied
Biosystems (ABI, Foster City, CA) TaqMan pre-designed as-
says were used for all genes as well as GAPDH as a control
internal housekeeping gene. Plates were read by a 7500 Fast
Real-Time PCR System using the 7500 Fast System Software
v1.4.0 (ABI). Quantitation of gene expression levels was cal-
culated from a standard curve created from reactions contain-
ing a combination of complementary DNA (cDNA) from all
treatments for each gene.
Immunofluorescent Microscopy
DU-145 cells were grown to 80 % confluency on glass
coverslips (Fisher Scientific, Pittsburg, PA) and treated
with either BA-free media, 10 μM BA, or 1 μM
thapsigargin. Antibodies were tested on immunoblots of
lysed cells prior to using them for immunohistochemistry.
Cells stained for ATF6 were first fixed with 4 % parafor-
maldehyde in PBS and permeabilized with 0.5 % Triton
X-100 in PBS. Fixed cells were blocked with 10 % FBS
in PBS overnight. The next day, they were moved to a
humidity chamber and incubated with anti-ATF6
(Imgenex, San Diego, CA) monoclonal antibody at a
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concentration of 1:50, followed by secondary Alexa 488
or FITC at 1:100. Coverslips were mounted with a mix-
ture of Vectashield with 4′,6-diamidino-2-phenylindole
(Vector Laboratories, Burlingame, CA) and regular
Vectashield HardSet (Vector Laboratories) mounting me-
diums at 1:5. Images were captured with an Olympus
DP72 camera (Olympus America, Center Valley, PA) con-
nected to an Olympus BX51 fluorescence microscope
(Olympus America) using an Olympus UIS2 UPlanFLN
100X/1.30 OilPh3 objective (Olympus America) and
FITC and DAPI filters. Olympus DP2-BSW (Olympus
America) or Adobe Photoshop (Adobe Systems
Incorporated, San Jose, CA) software was used to merge
and crop images.
XBP1 Cleavage Analysis
Total RNA was extracted from BA (0–250 μM)-treated or
thapsigargin (10 μM)-treated DU-145 cells using RNeasy
Mini Kit (Qiagen). RNA was reverse transcribed using
SuperScript III Reverse Transcriptase (Invitrogen). XBP1
cDNA was amplified with GoTaq Flexi DNA Polymerase
(Promega, Madison WI) using the forward primer 5ʹ-
CACCTGAGCCCCGAGGAG-3ʹ and reverse primer 5ʹ-
TTAGTTCATTAATGGCTTCCAGC-3ʹ [HGNC:12801;
NCBI Reference Sequence: NM_005080.3]. Fifty-microliter
PCR reactions were run under the following amplification
conditions: 95 °C for 2 min; 95 °C for 30 s, 60 °C for 30 s,
72 °C for 30 s, all for 25 cycles; and 72 °C for 5 min [26]. PCR
products were run on 2 % agarose E-gels with SYBR Safe
(Invitrogen) or 4 % ethidium bromide agarose gels (Fig. 11).
Statistical Analysis
SigmaStat 3.1 (Systat Software, Point Richmond, CA)
was used for analysis of data and selection of appropriate
statistical tests. Results of the statistical analysis for each
figure are provided in Supplement 1 Polysome profiles
were developed from untreated and BA-treated cells ob-
tained from paired culture plates processed in parallel.
Monosomes and polysomes were quantified by measuring
the area under the 80S monosomal peak and the area
under the polysomes using the trapezoidal area under the
curve method. The difference in means of polysome/
monosome ratios from three independent experiments
run on different days was evaluated using a paired t test.
Replicates of data in Figs. 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and
12 represent cells plated from different seedings on dif-
ferent days. Analysis of timed studies used a one-way
repeated measures analysis of variance to determine the
effect of treatment time. Differences between the mean at
pre-treatment time zero (control) and means at post-
treatment time points were evaluated using the Holm–
Sidak multiple comparison test. The number of replicates
for each significant time point is given in the figure leg-
ends and Supplement 1. ImageJ software (NIH, Bethesda,
MD) was used for immunofluorescence quantitation of
stained cells. Only cells with clear borders of the ER
and nucleus were selected for study. Mean intensity of
nuclear and cytoplasmic areas of identical size was deter-
mined using the histogram tool in RGB mode. For ATF6
images, the polygon tool was used to trace the outer edges
of the FITC and DAPI-stained areas and the ER was cal-
culated by subtracting the area of the DAPI from the area
of the FITC. Proof that DU-145 cells were capable of
activating the genes under study was obtained by treat-
ment with 1 μM thapsigargin, a strong inducer of ER
stress that activates apoptosis [27]. The statistical signifi-
cance of thapsigargin treatment in Figs. 2, 3, 4, 6, 8, 9,
10, and 12 was compared to treatment with its solvent
DMSO using a t test.
Availability of Supporting Data
Supplement 1 contains tables of statistical evaluations of the
data for each figure. Supplement 2 gives the ATCC karyotype
description of DU-145 and mutation status of genes available
in COSMIC and Ensemble in Tables 1–6 [28].
Results
BA Causes a Decrease in the Polysome/Monosome Ratio
Environmental conditions that stress ER function elicit a
response that inhibits global translation and selectively
enhances the transcription and translation of proteins
needed to alleviate the stress [29]. Transcripts that are
not translated form ribonuclear protein particles (mRNP)
that sediment at 20S to 35S. Messenger RNAs (mRNAs)
that are translated accumulate as 80S monosomes com-
posed of small (40S) and large (60S) ribosomal subunits
that travel along the mRNA during translational elonga-
tion. During protein synthesis, many monosomes can ini-
tiate translation on a single mRNA transcript to form a
polyribosome or polysome. Polysomes disassemble under
environmental conditions that inhibit protein synthesis,
and this results in a decrease in the polysome/monosome
ratio [30, 31]. We measured the areas under the 80S
monosomal peak and polysomes using the trapezoidal ar-
ea under the curve method. We show that treatment of
DU-145 cells with 10 μM BA reduced the polysome/
monosome ratio by approximately 54 %, demonstrating
that protein translation was significantly inhibited, but
not stopped (Fig. 1, Supplement 1).
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BA Induces Phosphorylation of eIF2α
The eIF2 complex is part of a large ternary complex
(eIF2–GTP–tRNAi Met) that positions the initiator methi-
onine at the first codon of mRNA to commence transla-
tion and protein synthesis. eIF2α is the regulatory subunit
of the eIF2 complex, and phosphorylation on serine 51
inhibits the formation of the eIF2–GTP–tRNAi Met com-
plex preventing the initiation of translation [32]. We mea-
sured phosphorylation of eIF2α at serine 51 in DU-145
cells treated with 10 μM BA. The proportion of eIF2α
phosphorylated (eIF2α phosphorylation/total eIF2α) was
mildly but significantly increased following 0.5, 1, and
2 h of treatment (Fig. 2a). The maximum increase in
phosphorylation was 125 % at 60 min after BA treatment.
As a positive control, we treated DU-145 cells with 1 μM
thapsigargin or DMSO (vehicle) for 1 h. Thapsigargin, a
strong inducer of ER stress [27], significantly induced
phosphorylation of eIF2α in DU-145 cells (Fig. 2b).
BA Induces GADD34 Transcription and Translation
GADD34 associates with protein phosphatase 1 and promotes
dephosphorylation of eIF2α [33]. BA treatment resulted in a
maximum increase in mRNA of 125 % at 2 h and increase of
protein of 53 % at 2 h (Figs. 7a and 3a, Table 1). Treatment
with thapsigargin also increased GADD34 protein (Fig. 3b).
BA Increases GRP78/BiP Transcription and Translation
Glucose-regulated protein (GRP78/BiP) is a major Ca2+-
binding protein in the ER and binds to and maintains the
three unfolded protein response (UPR) transmembrane
sensors ATF6, PERK, and IRE1 in an inactive form
[34, 35]. We measured GRP78/BiP in DU-145 cells treat-
ed with 10 μM BA. The maximum increase of mRNA
was 149 % at 30 min and of protein 98 % at 60 min
following BA treatment (Figs. 10a and 4a, Table 1).
DU-145 cells treated with thapsigargin also increased
GRP78/BiP protein (Fig. 4b).
BA Induces ATF4 Transcription and Translation
Phosphorylation of eIF2α selectively activates transcrip-
tion and translation of ATF4, a transcription factor in the
highly conserved integrated stress response (ISR) that en-
ables cells to survive in adverse environmental conditions.
We used RT-PCR to measure ATF4 transcription in DU-
145 cells treated with 10 μM BA. ATF4 mRNA was in-
creased at 1 and 2 h post-treatment (Fig. 5). The maxi-
mum increase in mRNA was 46 % at 2 h after BA treat-
ment (Table 1). ATF4 mRNA was also elevated in cells
treated with thapsigargin (Fig. 5). ATF4 protein was sig-
nificantly increased from 1 to 3 h followed by a decrease
at 5 h post-treatment (Fig. 6a). The maximum increase
was 53 % at 3 h (Fig. 6a, Table 1). Thapsigargin treatment
also increased ATF4 protein levels (Fig. 6b).
Fig. 1 BA induces a lower polysome/monosome ratio in DU-145 cells
indicating a reduction in global protein translation. DU-145 cells treated
with 10 μM BA for 2 h (a) had a significantly lower polysome/
monosome ratio than did DU-145 cells treated with 0 μM BA for 2 h
(b). Polysomes from untreated and BA-treated cells were obtained from
cells treated in parallel using paired culture plates and centrifuging
together in the same rotor. Figure shows a representative replicate. The
difference in polysome/monosome ratios from three independent
experiments was evaluated using a paired t test (p < 0.001, n = 3)
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BA Induces GADD34 and Herp but Decreases CHOP
Transcription
ATF4 moves into the nucleus where it activates genes that
either assist in cell survival by relieving ER stress or pro-
mote apoptosis in the case of lethal stresses [36].
GADD34 and homocysteine-induced ER protein (Herp)
are ATF4- inducib le survival genes , and CHOP
(GADD153), which is also induced by ATF4, is a pro-
apoptotic gene. We treated DU-145 cells with 10 μM
BA and used RT-PCR to analyze changes in mRNA
levels. GADD34, which provides a negative feedback
loop in the eIF2α/ATF4 pathway by dephosphorylating
ph-eIF2α, was significantly increased by 53 % 2 h after
treatment (Fig. 7a, Table 1) [36]. Herp is a protein in-
volved in ER-associated degradation (ERAD) that recruits
the 26S proteasome component to the ER membrane dur-
ing ER stress [36]. Herp mRNA was increased by 54 %
4 h after treatment (Fig. 7b, Table 1). In contrast, 10 μM
BA caused GADD153/CHOP mRNA expression to de-
crease. The maximum decrease in mRNA was −59 % at
12 h (Fig. 7c, Table 1).
BA Decreases CHOP Protein
We performed immunoblots to measure CHOP/GADD153
protein in DU-145 cells treated with 10 μM BA. CHOP pro-
tein expression was significantly decreased at 0.25, 2, 3, 4, 5,
and 6 h after treatment (Fig. 8a). The maximum decrease in
protein was −51 % at 3 h after BA treatment (Table 1). The
increase in CHOP protein expression following thapsigargin
treatment showed that DU-145 cells responded normally to a
Fig. 2 BA induces eIF2α phosphorylation at ser-51 in DU-145 cells. a
DU-145 cells were treated with 10 μM BA for 0, 0.25, 0.5, 1, 2, 3, 4, 5,
and 6 h. Phosphorylation of eIF2α was significantly higher at 0.5
(p < 0.006, n = 3), 1, (p < 0.001, n = 3), and 2 h (p < 0.005, n = 3)
post-treatment. bDU-145 cells were treated with 1 μM thapsigargin (Tg),
a strong positive control that induces stress and apoptosis, or DMSO
(DM), the vehicle for Tg for 1 h, p < 0.01, n = 3. In Figs. 2, 3, 4, 5, 6,
7, 8, 9, 10, 11, and 12, the probabilities of statistical differences are
represented as *p < 0.05, **p < 0.01, and ***p < 0.001. Gels shown in
Figs. 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 are a representative replicates of
timed studies. Timed study data were analyzed using a one-way repeated
measures analysis of variance (ANOVA) followed by a multiple
comparison of individual post-treatment time points to treatment time 0
(control). Supplement 1 contains the ANOVA table for each figure giving
the number of replicates for each time point and the results of the multiple
comparison of each post-treatment time point to treatment time 0
Fig. 3 BA induces an increase in GADD34 protein in DU-145 cells. a
DU-145 cells were treated with 10 μM BA for 0, 0.25, 0.5, 1, 2, 3, 4, 5,
and 6 h. GADD34 was increased in cells at 2 (p = 0.018, n = 3) and 3 h
(p = 0.011, n = 3). bDU-145 cells treated with 1 μM thapsigargin (Tg) or
DMSO (DM) for 1 h, (p < 0.05, n = 3). The gel shown is a representative
replicate. A description of the statistical analysis is given in the legend of
Fig. 2
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known stimulus of apoptosis (Fig. 8b). The BA-induced de-
crease in CHOP protein expression was consistent with our
observation that the same BA dose decreased CHOP mRNA
(Fig. 7c) and with previous findings that DU-145 cells do not
undergo apoptosis with BA treatment even at a concentration
of 1000 μM, a dose known to cause reproductive and devel-
opmental toxicity [14].
BA Induces ATF6 Activation
In response to ER stress, the ER resident protein, ATF6, is
translocated to the Golgi apparatus where it undergoes prote-
olysis by the S1P/S2P protease system. The resulting soluble
cytoplasmic fragments enter the nucleus and activate tran-
scription of target genes with ER stress response elements
(ERSEs), such as GRP78/BiP [37]. We measured the
proportion of cleaved ATF6 protein (p70) relative to the full
length (p100) and observed an increase 30 min post-treatment
(Fig. 9b). ATF6 measured using immunofluorescence was
present in the nucleus 1 and 2 h after treatment with 10 μM
BA (Fig. 9a). The maximum increase in ATF6 activation was
77 % at 30 min, and the increase in the p70/p100 ratio was
29 % at 2 h (Fig. 9a, b, Table 1).
BA Increases Transcription of ATF6 Target Genes
Cleaved ATF6 is a transcription factor for genes that contain
ERSEI in their promoter [36]. ATF6-inducible genes include
the two Ca2+-binding proteins GRP78/BiP and calreticulin as
well as GRP94 and XBP1 [38]. We measured the mRNA
levels of these genes by RT-PCR following treatment of
DU-145 cells. Ten-micromole BA treatment increased
Table 1 Time of maximum
response of untreated cells
(0 min) to treatment with 10 μm
boric acid
Gene (symbol(s)) Measured response; maximum
change; post-treatment timea
Eukaryotic translation initiation factor (EIF2A) Phosphorylation; +125 %; 60 min
Activating transcription factor 4 (ATF4)b mRNA; +46 %; 2 h
Protein; +53 %; 3 h
ATF4-activated genes
Growth arrest and DNA damage-inducible protein 34
(GADD34); Protein phosphatase 1 regulatory subunit 15A
(PPP1R15A)
mRNA; +125 %; 2 h
Protein; +53 %; 2 h
DNA damage inducible transcript 3 (CHOP;
GADD153; DDIT3)
mRNA; −59 %; 12 h
Protein; −51 %; 3 h
Homocysteine-inducible, endoplasmic reticulum
stress-inducible, ubiquitin-like domain member 1
(HERP, HERPUD1)
mRNA; +56 %; 4 h
Activating transcription factor 6A (ATF6A)c Cleavage p70/p100; +77 %; 30 min
Nuclear/cytoplasm staining; +29 %; 2 h
ATF6A-activated genes
Heat shock protein family A (Hsp70)
member 5 (GRP78; BiP; HSPA5)
mRNA; +149 %; 30 min
Protein; +98 %; 60 min
ER degradation enhancer, mannosidase
alpha-like 1 (EDEM1)
mRNA; +110 %; 24 h
Heat shock protein 90-kDa beta family
member 1 (GRP94; HSP90B1)
mRNA no change
Calreticulin (CALR) mRNA; +52 %; 8 h
X-box binding protein 1 (XBP1) mRNA; +147 %; 24 h
Endoplasmic reticulum to nucleus signaling 1 (IRE1; ERN1)c No change or negative change
IRE1-activated genes
X-box binding protein 1 spliced (XBP1s) Spliced XBP1 (XBP1s) was not
observed at 0–250 μM BA
Synoviolin 1 (HRD1; SYVN1) mRNA; −34 %; 24 h
aMaximum change from treatment with 10 μM boric acid was calculated using the mean of untreated cells
(0min) and the highest mean value post-treatment (data available in Supplement 1). Percent (%) change = [highest
post-treatment value − pre-treatment value (at 0 min)] ÷ [pretreatment value (at 0 min)]. Note that the first
significant change may have occurred earlier; see figures
b ATF4 is activated by low levels of EIF2α subsequent to EIF2α phosphorylation
c Stress sensor in the unfolded protein response stress pathway (UPR)
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GRP78/BiP mRNA 30 min after treatment (Fig. 10a) with a
maximum of 149 % (Table 1). The maximum increase in BiP/
GRP78 protein was 98 % at 1 h (Fig. 4, Table 1). GRP94 was
unchanged (Fig. 10b). Calreticulin mRNA increased by 49 %
at 4 h (Fig. 10c) with a maximum of 52 % at 8 h after BA
treatment (Fig. 10c, Table 1). XBP1 mRNA was increased
24 h post-treatment by 147 % (Fig. 10d, Table 1).
BA Does Not Activate the IRE1 Branch of UPR
An excessive accumulation of unfolded and misfolded pro-
teins in the ER causes IRE-1 to dimerize allowing trans-auto-
phosphorylation of juxtaposed kinase domains and activation
of their endoribonuclease domains located in the cytoplasm
[39]. Activated IRE1 splices XBP1 mRNA forming pXBP1s
(spliced XBP1 protein) that binds to the unfolded protein re-
sponse element (UPRE) [40]. To assess activation of the IRE1
branch of the UPR, we evaluated splicing of XBP1 mRNA
using a primer specific for both spliced and unspliced forms of
Fig. 6 BA induces an increase in ATF4 protein in DU-145 cells. a DU-
145 cells were treated with 10 μM BA for 0, 0.25, 0.5, 1, 2, 3, 4, 5, and
6 h. ATF4 protein was significantly increased in cells treated at 1
(p = 0.01, n = 4), 2 (p < 0.05, n = 3), and 3 h (p = 0.004, n = 3) and
decreased at 5 h (p < 0.030, n = 4) post-treatment. b ATF3 protein was
significantly increased in DU-145 cells treated with 1 μM thapsigargin
(Tg) or DMSO (DM) for 1 h, (p < 0.05 n = 3). The gel shown is a
representative replicate. A description of the statistical analysis is given
in the legend of Fig. 2
Fig. 5 BA induces an increase in ATF4 transcription in DU-145 cells.
Ten micromoles of BA induced a significant increase in ATF4 mRNA 1
(p = 0.031, n = 4) and 2 h (p = 0.005, n = 4) post-treatment. One
micromole of thapsigargin (Tg) and DMSO vehicle (DM) was used as
a positive control and significantly induced ATF4 mRNA, p < 0.05
(n = 5). The gel shown is a representative replicate. A description of the
statistical analysis is given in the legend of Fig. 2
Fig. 4 BA induces an increase in GRP78 (BiP) protein in DU-145 cells.
a DU-145 cells were treated with 10 μMBA for 0, 0.25, 0.5, 1, 2, 3, 4, 5,
and 6 h. GAPDH was used as an internal loading control. GRP78/BiP
translation was increased 0.5 (p = 0.028, n = 4), 1 (p = 0.007, n = 4), 2 h
(p = 0.032, n = 4), and 3 h (p = 0.013, n = 4). bDU-145 cells treated with
1 μM thapsigargin (Tg) or DMSO (DM) vehicle for 1 h (p < 0.05, n = 3).
The gel shown is a representative replicate. A description of the statistical
analysis is given in the legend of Fig. 2
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XBP1 mRNA. When PCR products are run slowly on an
agarose gel, the two forms separate into two bands of different
mass if IRE-1 is activated and XBP1 mRNA is spliced. We
treated DU-145 cells with BA concentrations from 10 to
250 μM for 24 h, and no splicing was observed (Fig. 11a).
We also treated DU-145 cells with 10μMBA for varying time
points and again did not observe spliced mRNA (Fig. 11b).
These results show that BA does not induce the IRE1 branch
of the UPR. Splicing was observed when cells were treated
with thapsigargin, a known activator of IRE1 (Fig. 11a, b).
BA Does Not Activate Hrd1, a Spliced XBP1-Specific
Target Gene
Spliced XBP1 that results from activation of the IRE1 branch
acts as a transcription factor for a number of UPR-related
genes. If BA activated IRE1, we would expect an increase in
the transcription of these genes. To confirm that BA did not
activate the IRE1 branch of the UPR, we used RT-PCR to
analyze the expression of Hrd1 and ER degradation enhancer
mannosidase alpha-like 1 (EDEM1). BA did not increase the
transcription of Hrd1 which is specifically activated by spliced
XBP1, but not ATF6 (Fig. 12a). EDEM1 is activated by both
ATF6 and XBP1 [40]. EDEM1 mRNAwas increased at 24 h
by treatment with 10 μM BA (Fig. 12b) probably due to ac-
tivation by ATF6.
Genes Were Active in the DU-145 Cell Line
The positive control, thapsigargin, demonstrated that all genes
evaluated were active in the DU-145 cell line. The Catalogue
of Somatic Mutations in Cancer (COSMIC) recorded a muta-
tion in ATF4 in 16.67 % of prostate tumor tissue samples [28].
In the DU-145 cell line, substitution mutations were reported
in ATF4 and IRE1 with no phenotypic changes. The muta-
tions did not occur in the regulatory build, and no association
was found for any gene measured and copy number or expres-
sion in the COSMIC Cell Line. Information available in
COSMIC (releases v75 and v76) and Ensemble for each of
the genes measured in this manuscript are available in
Supplement 2 [28, 41]. ATCC states that DU-145 Bis a
hypotriploid human cell line. Both 61 and 62 chromosome
numbers had the highest rate of occurrence in 30 metaphase
counts. The rate of higher ploides was 3 %. The t(11q12q),
del(11)q23), 16q+, del(9)(p11),del(1)(p32) and 6 other marker
chromosomes were found in most cells. The N13 was usually
absent. The Y chromosome is abnormal through translocation
Fig. 8 GADD153 (CHOP) protein was reduced in BA-treated DU-145
cells. aDU-145 cells treated with 10 μMBA for 0, 0.25, 0.5, 1, 2, 3, 4, 5,
and 6 h. GADD153 (CHOP) protein was decreased at 0.25 (p < 0.043,
n = 3), 2 (p < 0.033, n = 3), 3 (p < 0.015, n = 4), 4 (p < 0.006, n = 4), 5
(p < 0.014, n = 4), and 6 h (p < 0.003, n = 4). bDU-145 cells treated with
1 μM thapsigargin (Tg) or DMSO (DM) vehicle for 1 h. Thapsigargin
increased GADD153 (CHOP) protein, (p < 0.05, n = 3). The gel shown is
a representative replicate. A description of the statistical analysis is given
in the legend of Fig. 2
Fig. 7 ATF4-inducible genes GADD34 and Herp are upregulated and
CHOP downregulated by BA in DU-145 cells. Ten micromoles of BA
induced expression of a GADD34 at 2 h (p < 0.05), n = 4) and b Herp
(p < 0.001, n = 8)) at 4 h post-treatment and c downregulated expression
of GADD153 (CHOP) 12 h post-treatment (p = 0.012, n = 4). As a
positive control, 1 μM thapsigargin (Tg) upregulated expression of all
three genes compared to DMSO vehicle (DM), (p < 0.05, n = 3). A
description of the statistical analysis is given in the legend of Fig. 2
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to an unidentified chromosomal segment. The X chromosome
was present in single copy.^
Discussion
We describe in this paper the response of DU-145 human
prostate cells to concentrations of BA that occur from dietary
exposure. We draw seven main conclusions from our results.
First, BA reduces the polysome/monosome ratio, an indicator
of global protein translation. Changes to the extracellular en-
vironment can alter intracellular conditions that stress the ER
and inhibit global protein synthesis. Documented stresses
include low ER luminal [Ca2+]; nutrient stress from glucose
deprivation and amino acid deficiency; and toxic exposures
from chemical, physical, and biological hazards (NaN3, arse-
nite, oxidants, heat, UV radiation, and viruses) [42–44]. BA
treatment lowers luminal ER [Ca2+] as does thapsigargin, a
plant sesquiterpene lactone, used widely as a strong positive
control to assure that cells under study respond to a known ER
stressor [15]. ER stress elicits inhibition in global translation
by phosphorylation of eIF-2α which is a component of the
heterotrimeric eIF-2 complex that loads the initiator transfer
RNA (tRNA) (Met-tRNAMet) onto the 40S ribosomal sub-
unit [45–48]. The eIF-2 complex binds GTP/GDP, and its
activity is regulated by guanine nucleotide exchange factor
Fig. 9 BA stimulates ATF6
activation and translocation to the
nucleus. a ATF6 (green) was
present in the nucleus (blue) of
DU-145 cells 1 (p = 0.026,
n = 17) and 2 h (p = 0.002, n = 48)
post-treatment with 10 μM BA. b
ATF6 is activated by cleavage.
The proportion of the cleaved
product (p70) to full length (p100)
was significantly elevated 30 min
post-treatment (p = 0.032, n = 3).
One micromole of thapsigargin
(Tg) also significantly increased
the p70/p100 ratio (p < 0.05)
(n = 15). The gel shown is a
representative replicate. A
description of the statistical
analysis is given in the legend of
Fig. 2. (Color figure online)
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eIF-2B. Phosphorylation of eIF-2α increases the affinity of
eIF-2 for eIF-2B, preventing the exchange of GDP for GTP.
This prevents the formation of the puromycin-sensitive 80S
pre-initiation complex and allows elongating ribosomes to
release mRNAs, leading to the disassembly of polysomes into
monosomes [48]. Here, we show that BA (10 μM) treatment
reduced the polysome/monosome ratio by approximately half,
an indication that global protein synthesis was inhibited, but
not stopped (Fig. 1). Uluisik, Kaya, and colleagues reported
that 50 mM BA completely halted polysome formation and
protein synthesis in yeast [21].
Second, BA increases the transcription and translation
of BiP/GRP78, a resident ER chaperone, with a long half-
life (>48 h) and an indicator of ER stress (Figs. 4 and 10)
[36, 49]. BiP/GRP78 binds about 20 % of the ER’s Ca2+
and is the master regulator of the UPR [34, 50]. In eukary-
otic cells, newly synthesized secretory and transmembrane
unfolded polypeptides are transported through translocons
into the ER lumen. BiP/GRP78 gates the ER side of the
tranlocon [34, 51, 52], recognizes hydrophobic regions of
nascent unfolded proteins entering the ER, and assists in
their folding and assembly into polypeptides [53, 54]. High
[Ca2+]ER is required for protein folding, and when it is low,
unfolded proteins accumulate. BiP/GRP78 activates UPR
pathways via its release from resident ER transmembrane
proteins to remove the stress [50].
Fig. 10 BA upregulates ATF6-inducible genes BiP, GRP94, calreticulin,
and XBP1. Ten micromoles of BA induced expression of a GRP78 (BiP)
at 0.5 h (p < 0.001, n = 4). GRP78 returned to control levels for several
hours and then dropped to lower levels at 8 h (p < 0.001, n = 4), 12 h
(p < 0.001, n = 4), and 24 h (p < 0.001, n = 4), suggesting that the cells
adapted to higher concentrations of BA. b GRP94 was unchanged by
treatment. c Calreticulin was higher at 4 h (p < 0.001, n = 5) and 8 h
(p = 0.003, n = 4). d XBP1 was higher at 24 h of treatment (p < 0.001,
n = 4). As a positive control, 1 μM thapsigargin (Tg) upregulated
expression of all genes compared to DMSO vehicle (DM) (p < 0.05,
n = 4). The gel shown is a representative replicate. A description of the
statistical analysis is given in the legend of Fig. 2
Fig. 11 BA does not activate the IRE1 signaling pathway. a DU-145
cells were treated with 0, 10, 50, 100, or 250 μM BA or 1 μM
thapsigargin (Tg) for 24 h. Thapsigargin was used as a positive control.
Increasing BA concentrations for 24 h did not cause XBP1 cleavage. b
DU-145 cells were treated with 10 μM BA for varying time points or
1 μM thapsigargin (Tg) as a positive control. XBP1 was not cleaved at
any time point by BA, but it was by Tg (p < 0.05, n = 3). The gel shown is
a representative replicate
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Third, BA activation of eIF2α through phosphorylation at
serine 51 is transient. The interaction between BiP/GRP78 and
nascent unfolded proteins is stabilized by luminal ER Ca2+,
andwhen Ca2+ concentrations fall, BiP/GRP78 is released and
interacts with PERK, a kinase that phosphorylates eIF2α [50].
Treatment of cells with 10 μM BA significantly elevated the
ratio of phosphorylated eIF2α/total eIF2α at 30 min, and it
remained high up to 2 h (Fig. 2, Table 1). The decline in ph-
eif2α coincided with the rise in GADD34 mRNA, the phos-
phatase that removes the phosphate from ph-eIF2α (Fig. 7a).
Our observation of a return to normal suggests that the cell has
completed a change in transcription to the new 10-μM BA
environment by 3 h and that a comparison of polysomes be-
fore BA treatment and at 3 h would provide a means to iden-
tify BA-dependent changes in protein translation.
Fourth, BA upregulates the transcription factor, ATF4.
Phosphorylation of eIF2α increases upstream open reading
frame (uORF)-mediated translation of bone-related activating
transcription factor 4 (ATF4). The ph-eIF2α/ATF4 pathway is
highly conserved from yeast to mammals and has been named
the ISR because it is a target of many different types of envi-
ronmental stresses [55]. Treatment with BA resulted in an
increase in ATF4 mRNA and protein levels (Figs. 5 and 6,
Table 1). ATF4-inducible gene GADD34 increased immedi-
ately whereas the increase in Herp, which is dually regulated
by ATF6 and ATF4 [56], was delayed to 4 h (Fig. 7b). In
neurons, moderate levels of ER stress increase Herp levels,
which promotes cell survival by stabilizing ER Ca2+, preserv-
ing mitochondrial function and suppressing caspase 3, where-
as lethal stress levels decrease Herp levels and induce apopto-
sis [57]. In neuronal PC12 cells, promotion of cell survival is
accomplished by Herp’s association with ryanodine and ino-
sitol Ca2+ channels and facilitation of their proteasome-
mediated protein degradation [58].
Fifth, BA reduced the CHOP, also referred to as growth
arrest-inducible and DNA damage-inducible gene 153
(GADD153), at both the mRNA and protein levels (Figs. 7c
and 8). This outcome is consistent with previous reports show-
ing that BA does not cause apoptosis in DU-145 prostate cells
or MDA-MB-231 breast cancer cells at concentrations of
1 mM or less [5, 59]. The absence of CHOP activation by
BA is also consistent with the anti-apoptotic activity of BiP/
GRP78 and Herp and the absence of BA activation of IRE1
(Figs. 11 and 12a). This can be explained by the low level of
eIF2α phosphorylation induced by BA. A single uORF locat-
ed in the 5′-leader of the CHOP mRNA is responsible for
CHOP translation. In non-stress conditions and when eIF2α
phosphorylation is low, the uORF serves as a barrier that pre-
vents translation of the downstream CHOP coding region.
Lethal stress levels, such as those induced by thapsigargin,
induce a high level of eIF2α phosphorylation which facilitates
ribosome bypass of the uORF and allows translation [60].
Sixth, BA activates the ATF6 pathway. BA causes a
dose- and time-dependent expansion of the ER with the
formation of cytoplasmic stress granules (SGs) [19]. ER
expansion is induced by ATF6α [61] and independently
by pXBP1s via the IRE1 pathway [62, 63]. We show here
that treatment with BA activated ATF6α, but not IRE1
(Figs. 9, 10, 11, and 12). ATF6 is retained in the ER bound
to BiP/GRP78 and dissociates when unfolded proteins ac-
cumulate. ATF6 moves to the Golgi where it is cleaved by
S1P and S2P proteases to form a soluble basic leucine
zipper (bZIP) transcription factor that moves into the nu-
cleus [34]. Nuclear ATF6 binds to an ERSE promoter lo-
cated upstream of target genes which include BiP/GRP78,
calreticulin, and XBP1 [40]. Calreticulin mRNA increased
by 49 % at 4 h (Fig. 10c). Calreticulin is a major ER Ca2+-
binding protein and increases luminal Ca2+ stores [64, 65].
As a chaperone, it recognizes the terminal glucose and four
internal mannoses in newly synthesized glycoproteins
[66]. Reductions in ER Ca2+ decrease the formation of
these complexes and ER folding capacity. Calreticulin fa-
cilitates the folding of major histocompatibility complex
(MHC) class I molecules and their assembly factor tapasin,
Fig. 12 BA does not activate the XBP1s-inducible gene Hrd1, but did
activate Edem1 which is also induced by ATF6 and XBP1. a Ten
micromoles of BA did not induce expression of Hrd1 mRNA in DU-
145 cell which dropped below pre-treatment values at 2 h (p < 0.05,
n = 4) and 24 h (p < 0.05, n = 3). b Ten micromoles of BA induced
expression of Edem1 at 24 h (p < 0.001, n = 4) which is regulated by
ATF6 and IRE1. As a positive control 1 μM thapsigargin (Tg)
upregulated expression of both genes compared to DMSO vehicle
(DM), (n = 6). The gel shown is a representative replicate. A description
of the statistical analysis is given in the legend of Fig. 2
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thereby influencing antigen presentation to cytotoxic T
cells [67, 68]. It is also required for the stability and nucle-
ar localization of the p53 protein [69]. Further studies are
needed to determine if the ability of BA to induce
calreticulin transcription is related to its effects on the im-
mune system [11].
The second ATF6-regulated gene we evaluated was BiP/
GRP78. In HeLa cells, thapsigargin induced rapid BiP trans-
lation that preceded transcription [70]. The authors suggested
that storage of BiP/GRP78 mRNA transcripts allows cells to
rapidly synthesize the protein to adapt to small perturbations
and reserve transcriptional upregulation for conditions that
cause major reductions in the protein level [70].
ATF6 induces XBP1 mRNA under mild stress whereas
higher levels of stress induce XBP1 and IRE1-dependent
XBP1(s) [40]. ATF6α forms a heterodimer with XBP1 which
induces ER degradation enhancing α-mannosidase-like 1
(EDEM1). EDEM1 enhances the release of terminallymisfolded
glycoproteins from the calnexin chaperone system. In our study,
XBP1 and EDEM1 mRNAwere increased by 147 and 110 %,
respectively, at the 24-h BA treatment (Fig. 12b, Table 1).
Seventh, BA does not activate IRE1. The IRE1 pathway
transactivates the transcription of genes encoding ER chaper-
ones and components required for ERAD [71]. High levels of
stress induce XBP1 and XBP1(s) which is translated into the
XBP1 transcription factor protein [pXBP1(s)] that binds to
ERSE and UPRE DNA-binding sites to induce expression of
ER chaperones [40]. IRE1 is required for the site-specific
cleavage of XBP1 mRNA into fragments that are subsequent-
ly ligated to form the transcript encoding pXBP1(s). We did
not observe XBP1 cleavage in BA-treated cells at various
doses and time points (Fig. 11) nor was there an increase in
transcription of Hrd1, a pXBP1(s)-activated gene (Fig. 12a).
In previous studies using DU-145 and LNCaP prostate can-
cer cells, we showed that long-term exposure to BA (8 days)
induces a senescent-like state and inhibits proliferation in a
dose-dependent manner [5]. Long-term exposure to high con-
centrations of BA (250 and 1000 μM) inhibited both cell mi-
gration and invasion [72]. Bradke and colleagues extended
these observations to shorter periods of exposure and showed
that a 24-h exposure to 1000 μM BA inhibited migration of
DU-145 cells on fibronectin [73]. The concentrations used in
these migration studies are above what human cells would be
exposed to from normal dietary intake and occupational expo-
sure [13]. Dose response studies are needed in migration and
other studies to clarify those responses that can be achieved by
dietary B intake and those that require pharmaceuticals. The
observations presented here suggest caution in interpreting ge-
netic responses to BA since they are time dependent.
Understandably, this makes the results of single time-point
studies using arrays of multiple genes particularly challenging
to interpret. It also seems prudent that BA-sensitive periods be
identified prior to conducting dose response experiments.
Conclusion
Dietary boron has been connected to three seemingly uncon-
nected observations, increased bone mass and strength [10,
74, 75], chemoprevention [1, 3, 4, 6], and prevention of retinal
degeneration [76]. BiP/GRP78 is expressed in the mineraliz-
ing matrices of teeth and bone and in the extracellular matrix
of differentiating human marrow stromal cells and dental pulp
stem cells. BiP/GRP78 binds to type I collagen and dentin
matrix protein 1 and aids in the nucleation of calcium phos-
phate [77]. ATF4 regulates osteogenesis during development
and postnatal bone remodeling and upregulates osteocalcin
[78]. Parathyroid hormone, an essential regulator of endo-
chondral bone formation and an important anabolic agent for
the reversal of bone loss, mediates its functions in part by
regulating the binding of ATF4 to the osteoblast-specific gene,
osteocalcin [79]. BiP/GRP78 and EDEM prevent aggregation
of misfolded opsin leading to retinal degeneration [80, 81].
Our present observation that BA increased both BiP/GRP78
and EDEM provides a hypothesis for the observed retinal
degeneration in B-depleted zebrafish [76].
BA inhibits the cADPR Ca2+ pathway which activates cell
proliferation and inhibits differentiation [15, 82] and activates
TIA-1 [18] which has been reported to inhibit tumor progres-
sion and invasion [83]. Here, we show that BA treatment
increased GRP78 which inhibits cell migration [84] and
calreticulin which suppresses prostate cancer by inhibiting
growth and metastasis [85]. Calreticulin is also necessary for
p53 function an important tumor suppressor [69].The eIF2α/
ATF4 and ATF6 pathways are downregulated in genetic
models of prostate cancer, and their activation by BA is con-
sistent with its reported chemopreventative effect in human
populations [86].
Our studies were performed at a BA concentration that can
be achieved by diet. The median consumption of boron in the
USA ranges from 0.75 to 1.35 mg B/day in adults and is
derived primarily from dietary plants. Borates provide the
essential diester link between chains of the pectic polysaccha-
ride rhamnogalactanuran II (RG-II) that is essential for plant
growth. RGII occurs in the cell walls of gymnosperms and
angiosperms and is a soluble plant fiber that constitutes 15–
30 % of dietary fiber [87]. Boron-rich food sources include
tree nuts and peanuts, fruits, vegetables, legumes, and wine
which, along with olive oil, are the signature of the
Mediterranean diet. The NIH-AARP study reported that this
diet decreased cancer mortality by 17 % in men and 13 % in
women during a 5-year study period [88]. Determining how
important boron was to this outcome will require teasing out
the relative contributions of dietary components. In the mean-
time, we find it of interest that coffee in North America and
soybeans in China are the major contributors of boron to the
diet [89, 90], and both have been associated with reduced risk
of prostate cancer [91, 92].
290 Kobylewski et al.
Acknowledgments UC Toxic Substances and Training Grant to the
UCLA Molecular Toxicology Program provided partial support for SK,
KH, and KY. Other support was provided from remunerations for teach-
ing for CE.
Authors’ Contributions All authors contributed intellectually to this
manuscript. SK, KH, and KY conducted the experiments, analyzed data,
and prepared figures and manuscript drafts. CE performed the statistical
analysis of data and prepared the final manuscript, Table 1, and
Supplements 1 and 2.
Compliance with Ethical Standards This article does not contain any
studies with human or animal subjects performed by any of the authors.
Conflict of Interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons Attr ibution 4.0 International License (http: / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Barranco W, Hudak P, Eckhert C (2007a) Evaluation of ecological
and in vitro effects of boron on prostate cancer risk. Cancer Causes
Control 18:71–77
2. Barranco W, Hudak P, Eckhert CD (2007b) Erratum: evaluation of
ecological and in vitro effects of boron on prostate cancer risk.
Cancer Causes Control 18:583–584
3. Cui Y, Winton M, Zhang Z, Rainey C, Marshall J, et al. (2004)
Dietary boron intake and prostate cancer risk. Oncol Rep 11:887–
892
4. Muezzinoglu T, Korkmaz M, Nese N, Bakirdere S, Arslan Y, et al.
(2011) Prevalence of prostate cancer in high boron-exposed popu-
lation: a community-based study. Biol Trace Elem Res
5. Barranco W, Eckhert C (2004) Boric acid inhibits prostate cancer
cell proliferation. Cancer Lett 216:21–29
6. Mahabir S, Spitz MR, Barrera SL, Dong YQ, Eastham C, et al.
(2008) Dietary boron and hormone replacement therapy as risk
factors for lung cancer in women. Am J Epidemiol 167:1070–1080
7. Penland JG (1998) The importance of boron nutrition for brain and
psychological function. Biol Trace Elem Res 66:299–317
8. Meacham S, Taper L, Volpe S (1994) Effects of boron supplemen-
tation on bone mineral density and dietary, blood, and urinary cal-
cium, phosphorus, magnesium, and boron in female athletes.
Environ Health Perspect 102(Suppl.7):79–82
9. Chapin RE, WW K, Kenney A, McCoy H, Gladen B, et al. (1997)
The effects of dietary boron on bone strength in rats. Fundam Appl
Toxicol 35:205–215
10. Nielsen FH, Stoecker BJ (2009) Boron and fish oil have different
beneficial effects on strength and trabecular microarchitecture of
bone. J Trace Elem Med Biol 23: 195–203.
11. Hunt CD (2003) Dietary boron: an overview of the evidence for its
role in immune function. J Trace Elem Exper Med 16:291–306
12. IOM (2001) Dietary reference intakes for vitamin a, vitamin K,
arsenic, boron, chromium, copper, iodine, iron, manganese, molyb-
denum, nickel, silicon, vanadium, and zinc. National Academy
Press, Washington, D.C.
13. Culver BD, Shen PT, Taylor TH, Lee-Feldstein A, Anton-Culver H,
et al. (1994) The relationship of blood- and urine-boron to boron
exposure in borax-workers and the usefulness of urine-boron as an
exposure marker. Environ Health Perspect 102(Suppl 7):133–137
14. Barranco W, Eckhert CD (2006) Cellular changes in boric acid-
treated DU145 prostate cancer cells. Br J Cancer 94:884–890
15. Henderson K, Stella J, Kobylewski SL, Eckhert CD (2009)
Receptor activated Ca2+ release is inhibited by boric acid in pros-
tate cancer cells. PLoS One 4:e6009
16. Kim DH, Hee QS, Norris A, Faull KF, Eckhert CD (2006) Boric
acid inhibits ADP-ribosyl cyclase non-competitively. J
Chromatography A 1115:246–252
17. BlausteinMP, Golovina VA (2001) Structural complexity and func-
tional diversity of endoplasmic reticulum Ca2+ stores. Trends
Neurosci 24:602–608
18. Henderson K, Kobylewski S, Yamada K, Eckhert C (2015) Boric
acid induces cytoplasmic stress granule formation, eIF2 alpha
physphorylation, and ATF4 in prostate DU-145 cells. Biometals
28:133–141
19. Henderson KA, Eckhert CD (2006) Boric acid induces ER stress
and UPR in human prostate DU-145 and LNCaP cancer cells.
FASEB J 20:A560
20. Henderson KA (2009) Boric acid localization and effects on storage
calcium release and the endoplasmic reticulum in prostate cancer
cells. Dissertation, University of California Los Angeles
21. Uluisik I, Kaya A, Formenko DE, Karakaya HC, Carlson BA, et al.
(2011) Boron stress activates the general amino acid control mech-
anism and inhibits protein synthesis. PLoS One 6:e27772
22. Wallace J, Hannon-Fletcher M, Robson P, Gilmore W, Hubbard S,
et al. (2002) Boron supplementaton and activated factor VII in
healthy men. Eur J Clin Nutr 56:1102–1107
23. Litovita T, Klein-SchwartzW, OderdaG, Schmitz B (1988) Clinical
manifestation of toxicity in a series of 784 boric acid ingestions. Am
J Emerg Med 6:209–213
24. ATCC. https://www.atcc.org. Accessed 22 Jan 2016
25. Bennett A, Rowe RI, Soch N, Eckhert CD (1999) Boron stimulates
yeast (Saccharomyces cerevisiae) growth. J Nutr 129:2236–2238
26. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001)
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor. Cell 107:881–891
27. Lytton J, Westlin M, Hanley MR (1991) Thapsigargin inhibits the
sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calci-
um pumps. J Biol Chem 266:17067–17071
28. Forbes S, Beare D, Gunasekaran P, LeungK, Bindal N, et al. (2015)
COSMIC: exploring the world’s knowledge of somatic mutations
in human cancer. Nucl Acids Res 43 (D!): D805-D811.
29. Ron D (2002) Translational control in the endoplasmic reticulum
stress response. J Clin Investig 110:1383–1388
30. Spirin AS (1996) Masked and translatable messenger ribonucleo-
proteins in higher eukaryotes. In: Hershey SWB, Mathews MB,
Sonenberg N (eds) Translational control. Cold Spring Harbor Lab.
Press, Cold Spring Harbor, NY, pp. 319–334
31. Kedersha NL, Gupta M, Li W, Miller I, Anderson P (1999) RNA-
binding proteins TIA-1 and TIAR link the phosphorylation of eIF-
2a to the assembly of mammalian stress granules. J Cell Biol 147:
1431–1441
32. Zoll WL, Horton LE, Komar AA, Hensold JO, MerrickWC (2002)
Characterization of mammalian eIF2A and identification of the
yeast homolog. J Biol Chem 277:37079–37087
33. Brush MH, Weiser DC, Shenolikar S (2003) Growth/arrest and
DNA damage-inducible protein GADD34 targets protein phospha-
tase 1α to the endoplasmic reticulum and promote dephosphoryla-
tion of the α subunit of eukaryotic translation initiation factor 2.
Mol Cell Biol 23:1292–1303
Boric Acid Activation of the EIF2α/ATF4 and ATF6 Pathways 291
34. Hendershot LM (2004) The ER chaperone BiP is the master regu-
lator of ER function. Mount Sinai. J Med 71:289–297
35. Pfaffenbach KT, Lee AS (2011) The critical role of GRP78 in phys-
iologic and pathologic stress. Curr Opin Cell Biol 23:150–156
36. Schroder M, Kaufman RJ (2005) The mammalian unfolded protein
response. Annu Rev Biochem 74:739–789
37. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Kazutoshi M
(2004) Differential contributions of ATF6 and XBP1 to the activa-
tion of endoplasmic reticulum stress-responsive cis-acting elements
ERSE, UPRE and ERSE-II. J Biochem 136:343–350
38. Conn PM (2011) In: Conn PM (ed) Methods in enzymology.
Academic Press, London
39. Zhou J, Liu CY, Back SH, Clark RL, Peisch D, et al. (2006) The
crystal structure of human IRE1 luminal domain reveals a con-
served dimerization interface required for activation of the unfolded
protein response. Proc Natl Acad Sci U S A 103:14343–14348
40. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, et al. (2007)
Transcriptional induction of mammalian ER quality control pro-
teins is mediated by single or combined action of ATF6alpha and
XBP1. Dev Cell 13:365–376
41. Ensemble. http://www.ensembl.org/index.html. Accessed 15
Jan 2016
42. Anderson P, Kedersha N (2008) Stress granules: the Tao of RNA
triage. Trends Biochem Sci 33:141–150
43. Zhu Y, Fenik P, Zhan G, Sanfillipo-Cohn B, Naidoo N, et al. (2008)
Eif-2a protects brainstem motoneurons in a murine model of sleep
apnea. J Neurosci 28:2168–2178
44. Carew JS, Nawrocki ST, Krupnik YV, Dunner K Jr, McConkey DJ,
et al. (2006) Targeting endoplasmic reticulum protein transport: a
novel strategy to kill malignant B cells and overcome fludarabine
resistance in CLL. Blood 107:222–231
45. Berlangad J, Herrero S, De Haro C (1998) Characterization of the
hemin-sensitive eukaryotic initiation factor 2a kinase from mouse
nonerythroid cells. J Biol Chem 273:32340–32346
46. Gray NK, Wickens M (1998) Control of translation initiation in
animals. Annu Rev Cell Dev Biol 14:399–458
47. Srivastava SP, Kumar KU, Kaufman RJ (1998) Phosphorylation of
eukaryotic translation initiation factor 2 mediates apoptosis in re-
sponse to activation of the double-stranded RNA-dependent protein
kinase. J Biol Chem 273:2416–2423
48. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding
are coupled by an endoplasmic-reticulum resident kinase. Nature
397:271–274
49. Hendershot LM, Kearney JF (1988) A role for human heavy chain
binding protein in the developmental regulation of immunoglobin
transport. Mol Immun 25:585–595
50. Lievremont JP, Rizzuto R, Hendershot L, Meldolesi J (1997) BiP, a
major chaperone protein of the endoplasmic reticulum lumen, plays
a direct and important role in the storage of the rapidly exchanging
pool of Ca2+. J Biol Chem 272:30873–30879
51. Van Coppenolle F, Vanden Abeele F, Slomianny C, Flourakis M,
Hesketh J, et al. (2004) Ribosome-translocon complex mediates
calcium leakage from endoplasmic reticulum stores. J Cell Sci
117:4135–4142
52. Schauble N, Lang S, Jung M, Cappel S, Schorr S, et al. (2012) BiP-
mediated closing of the Sec61 channel limits Ca2+ leakage from the
ER. EMBO J 31:3282–3296
53. Haas IG, Wabl M (1983) Immunoglobulin heavy chain binding
protein. Nature 306:387–389
54. Bole DG, Hendershot LM, Kearney JF (1986) Posttranslational
association of immunoglobulin heavy chain binding protein with
nascent heavy chains in nonsecreting and secreting hybridomas. J
Cell Biol 102:1558–1556
55. Harding H, Zhang Y, Zeng H, Novoa I, Lu P, et al. (2003) An
integrated stress response regulates amino acid metabolism and
resistance to oxidative stress. Mol Cell 11:619–633
56. Ma Y, Hendershot L (2004) Herp is dually regulated by both the
endoplasmic reticulum stress-specific branch of the unfolded pro-
tein response and a branch that is shared with other cellular stress
pathways. J Biol Chem 279:13792–13799
57. Chan SL, Fu W, Zhang P, Cheng A, Lee J, et al. (2004) Herp
stabilizes neuronal Ca2+ homeostasis and mitochondrial function
during endoplasmic reticulum stress. J Biol Chem 279:28733–
28743
58. Belal C, Ameli NJ, El Kommos A, Bezalel S, Al’Khafaji AM, et al.
(2012) The homocysteine-inducible endoplasmic reticulum (ER)
stress protein Herp counteracts mutant α-synuclein-induced ER
stress via the homeostatic regulation of ER-resident calcium release
channel proteins. Hum Mol Genet 21:963–977
59. Scorei R, Ciubar R, Ciofrangeanu C, Mitran V, Cimpean A, et al.
(2008) Comparative effects of boric acid and calcium fructoborate
on breast cancer cells. Biol Trace Elem Res 122:197–205
60. Palam LR, Baird TD, Wek RC (2011) Phosphorylation of eIf2
facilitates ribosomal bypass of an inhibitory upstream ORF to en-
hance CHOP translation. J Biol Chem 286:10939–10949
61. Bommiasamy H, Back SH, Fagone P, Lee K, Meshinchi S, et al.
(2009) ATF6-alpha induces XBP1-independent expansion of the
endoplasmic reticulum. J Cell Sci 122:1626–1636
62. Sriburi R, Jackowski S, Mori K, Brewer JW (2004) XBP1: a link
between the unfolded protein response, lipid biosynthesis, and bio-
genesis of the endoplasmic reticulum. J Cell Biol 167:35–41
63. Sriburi R, Bommiasamy H, Buldak GL, Robbins GR, Frank M,
et al. (2007) Coordinate regulation of phospholipid biosynthesis
and secretory pathway gene expression in XBP-1(S)-induced endo-
plasmic reticulum biogenesis. J Biol Chem 282:7024–7034
64. Michalak M, Parker MM, Opas M (2002) Ca2+ signaling and cal-
cium binding chaperones of the endoplasmic reticulum. Cell
Calcium 32:269–278
65. Nakamura K, Zuppini A, Arnaudeau S, Lynch J, Ahsan I, et al.
(2001) Functional specialization of calreticulin domains. J Cell
Biol 154:961–972
66. Trombetta ES (2003) The contribution of N-glycans and their pro-
cessing in the endoplasmic reticulum to glycoprotein biosynthesis.
Glycobiology 13: 77R-91R.
67. Raghavan M, Wijeyesakere SJ, Peters LR, Del Cid N (2013)
Calreticulin in the immune system: ins and outs. Trends Immunol
34:13–21
68. Gao B, Adhikari R, Howarth M, Nakamura K, Gold MC, et al.
(2002) Assembly and antigen-presenting function of MHC class I
molecules in cells lacking the ER chaperone. Immunity:99–109
69. Mesaeli N, Phillipson C (2004) Impaired p53 expression, function,
and nuclear localization in calreticulin-deficient cells. Mol Biol Cell
15:1862–1870
70. Gulow K, Bienert D, Hass IG (2002) BiP is feed-back regulated by
control of protein translation efficiency. J Cell Sci 115:2443–2452
71. Yoshida H, Matsui T, Hosokawa N, Kaufman R, Nagata K, et al.
(2003) A time-dependent phase shift in the mammalian unfolded
protein response. Dev Cell 4:265–271
72. Barranco W, Eckhert C (2006) Cellular changes in boric acid-
treated DU-145 prostate cancer cells. Br J Cancer 94:884–890
73. Bradke TM, Hall C, Carper SW, Plopper GE (2008) Phenylboronic
acid selectively inhibits human prostate and breast cancer cell mi-
gration and decreases viability. Cell Adhesion and. Migration 2:
153–160
74. Hunt C (1994) Biochemical effects of physiological amounts of
dietary boron in animal models. Environ Health Perspect
102(Suppl 7):35–43
75. Armstrong TA, Spears JW (2003) Effect of boron supplementation
of pig diets on the production of tumor necrosis factor-a and inter-
feron-g. J Anim Sci 81:2552–2561
292 Kobylewski et al.
76. Eckhert CD, Rowe RI (1999) Embryonic dysplasia and adult retinal
dystrophy in boron-deficient zebrafish. J Trace Element Exp Med
12:213–219
77. Ravindran S, Gao Q, Ramachandran A, Sundivakkam P, Tiruppathi
C, et al. (2012) Expression and distribution of grp-78/bip in miner-
alizing tissues and mesenchymal cells. Histochem Cell Biol 138:
113–125
78. Wang W, Lian N, Ma Y, Li L, Gallant RC, et al. (2012)
Chondrocytic Atf4 regulates osteoblast differentiation and function
via Ihh. Development 139:601–611
79. Danciuk TE, Li Y, Koh A, Xiao G, McCauley LK, et al. (2012) The
basic helix loop helix transcription factor Twist1 is a novel regulator
of ATF4 in osteoblasts. J Cell Biochem 113:70–79
80. Kroeger H, Mesah C, Ahern K, Gee J, Joseph V, et al. (2012)
Induction of endoplasmic reticulum stress genes, BiP and Chop,
in genetic and environmental models of retinal degeneration.
Invest Ophthalmol Vis Sci 53:7590–7599
81. Kosmaoglou M, Kanuga N, Aguila M, Garriga P, Cheetham E
(2009) A dual role for EDEM1 in the processing of rod opsin. J
Cell Sci 122:4465–4472
82. Yue J, Wei W, Lam CMC, Zhao Y-J, Dong M, et al. (2009)
CD38/cADPR/Ca2 pathway promotes cell proliferation and delays
nerve growth factor-induced differentiation in PC12 cells*. J Biol
Chem 284: 29335–29335.
83. Izquierdo JM, Alcalde J, Carrascoso I, Reyes R, LudenaMD (2011)
Knockdown of T-cell intracellular antigens triggers cell prolifera-
tion, invasion and tumour growth. Biochem J 435:337–344
84. Wei PL, Kuo LJ, Wang W, Lin FY, et al. (2012) Silencing of
glucose-regulated protein 78 (GRP78) enhances cell migration
through the upregulation of vimentin in hepatocellular carcinoma
cells. Ann Surgical Oncol 19:S572–S579
85. AlurM,NguyenMM, Eggener SE, Jiang F, Dadras SS, et al. (2009)
Suppressive roles of calreticulin in prostate cancer growth and me-
tastasis. Am J Pathol 175:882–890
86. So AY-L, de la Fuente E, Walter P, Shuman M, Bernales S (2009)
The unfolded protein response during prostate cancer development.
Cancer Metastasis Rev 28:219–223
87. O’Neill MA, Warrenfeltz D, Kates K, Pellerin P, Doco T, et al.
(1996) Rhamnogalacturonan-II, a pectic polysaccharide in the
walls of growing plant cell, forms a dimer that is covalently
cross-linked by a borate ester. In vitro conditions for the for-
mation and hydrolysis of the dimer. J Biol Chem 271:22923–
22930
88. Mitrou PN, Kipnis V, Thiebaut ACM, Reedy J, Subar AF, et al.
(2007) Mediterranean dietary pattern and prediction of all-cause
mortality in a US population: results from the NIH-AARP Diet
and Health Study. Arch Intern Med 167:2461–2468
89. Rainey CJ, Nyquist LA, Christensen RE, Strong PL, Culver D,
et al. (1999) Daily boron intake from the American diet. J Am
Diet Assoc 99:335–340
90. Song X, Li F, Liu Z, Zhang L, Zhu J, et al. (2011) Boron back-
ground value survey of some foodstuffs in 12 provinces of China
and boron primary intake estimation of Chinese habitants. Wei
Sheng Yan Jiu 40:431–433
91. Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM,
et al. (2011) Coffee consumption and prostate cancer risk and pro-
gression in the health professionals follow-up study. J Natl Cancer
Inst 103:876–884
92. Yan L, Spitznagel EL (2009) Soy consumption and prostate cancer
risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89:1155–
1163
93. WHO (1998) Boron, environmental health criteria 204.
International Programme on Chemical Safety. World Health
Organization, Geneva, pp 61–65
94. Jansen A, Andersen J, Schou JS (1984) Boric acid single dose
pharmacokinetics after intravenous administration to man. Arch
Toxicol 55:64–67
Boric Acid Activation of the EIF2α/ATF4 and ATF6 Pathways 293
